News
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
When former President Joe Biden revealed he had been diagnosed with prostate cancer earlier this year, it reignited a ...
The FDA has approved darolutamide without chemotherapy for treatment of metastatic hormone-sensitive prostate cancer.The FDA ...
The approval was supported by data from the randomized, double-blind, placebo-controlled, phase 3 ARANOTE trial.
FDA approves Bayer's Nubeqa with ADT for metastatic hormone-sensitive prostate cancer, cutting death risk by 46%. Read more ...
Global Akeega sales will reach $676 million by 2030, while Talzenna and saruparib reach $618 million and $628 million ...
Men’s Health Month 2025 encourages men to adopt preventive care and healthy lifestyle habits to improve overall health ...
Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...
An international trial found combining a chemotherapy drug with an immunotherapy bladder cancer treatment is simple, safe and ...
Discover how Lacey Mayor Andy Ryder benefited from CyberKnife's non-invasive treatment, changing his life in just five days.
Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...
By Carla K. Johnson, Associated Press Former President Joe Biden has been diagnosed with aggressive prostate cancer and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results